Pfizer ends research for Alzheimer's, Parkinson's drugs

The drug company - which makes the lucrative drug, Viagra - said it was ending its neuroscience research to focus on areas where it was strongest.

by

    Alzheimer's and Parkinson's sufferers have been dealt a blow, with drug maker Pfizer deciding to end its research into the debilitating diseases.

    Many sufferers and their families had felt new hope when the pharmaceutical giant began early-stage research, but the company has now decided to invest elsewhere.

    Al Jazeera's John Hendren reports.


    YOU MIGHT ALSO LIKE

    The shocking story of Israel's disappeared babies

    The shocking story of Israel's disappeared babies

    New information has come to light about thousands of mostly Yemeni children believed to have been abducted in the 1950s.

    Stories from the sex trade

    Stories from the sex trade

    Dutch sex workers, pimps and johns share their stories.

    Inside the world of India's booming fertility industry

    Inside the world of India's booming fertility industry

    As the stigma associated with being childless persists, some elderly women in India risk it all to become mothers.